Shanghai Pharmaceutical Company Limited operates within the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Shanghai Pharmaceutical Company Limited with three other
drug stores in Asia:
Alfresa Holdings Corporation
sales of 2.58 trillion Japanese Yen [US$23.19 billion]
of which 88%
was Wholesale Business of Pharmaceuticals fo),
Suzuken Co., Ltd.
(2.23 trillion Japanese Yen [US$20.05 billion]
of which 93%
was Pharmaceutical Wholesale Business), and
Toho Holdings Company Limited
based in Japan
(1.31 trillion Japanese Yen [US$11.78 billion]
of which 92%
was Pharmaceutical Wholesale Business).
During the year ended December of 2016, sales at
Shanghai Pharmaceutical Company Limited were 120.76 billion Chinese Renmimbi (US$17.55 billion).
increase of 14.5%
versus 2015, when the company's sales were 105.52 billion Chinese Renmimbi.
This was the fifth consecutive year of sales increases at Shanghai Pharmaceutical Company Limited
(and since 2011, sales have increased a total of 120%).